KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/09/2026 13:13
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization23,852 mln
Float5.13 mln
Earnings Date08/18/2025
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.5
Borderline
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
1.09
Elevated leverage
Pre-Tax Margin
-85%
Severely loss-making
ROE
-35.04
Deeply negative
Business Description
Established over six decades ago, Aprogen Biologics Inc. is a Seoul-based company focused on bringing medical treatments to the South Korean market. It develops and distributes a range of pharmaceutical goods to serve patients and healthcare providers across the country.
